Evidence map›Paper›PMID 36651262›Full record

ReviewNan fang yi ke da xue xue bao = Journal of Southern Medical University2022

[An update of understanding of the hepatic vascular system and new research strategies].

Y Lin, Z Liu, M Dong, W Zhou

Open access · greenAbstract readReviewEnglish Abstract
In one paragraph

Review in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Y LinDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Z LiuDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
M DongDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
W ZhouDepartment of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Nanfang Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although the portal vessels, liver sinusoids, and central vessels are known to contain microvessels with different structures and functions, their changes and roles in liver fibrogenesis have not been fully understood. Recent studies suggest that in mouse models of liver fibrogenesis, vascular changes can occur at a very early stage, and different liver vessels undergo different changes and play different roles, as shown by a decreased number of portal vessels, increased sinusoid capillarization and increased central vessels. The increase of portal vessels alleviates liver fibrosis, while the increase of central vessels and sinusoid capillarization aggravates liver fibrosis. A full understanding of the regulatory mechanisms of each of these vessels is vital for treatment of liver fibrosis. A combined regulation of different endothelial cell (EC) regulatory signaling pathways for vascular normalization may provide new strategies for liver fibrosis therapy. Further studies of the changes and functions of blood vessels in different liver diseases, liver development and regeneration may bring about important breakthroughs. This review summarizes the changes of 3 hepatic microvessels and their roles in liver fibrogenesis and propose the major directions of future studies in this field.

Indexed as

LiverResearch DesignAnimalsCapillariesFibrosisLiver CirrhosisMiceangiogenesiscentral veinhepatic vascular systemportal veinsinusoid capillarization

Identifiers

PMID36651262
PMCPMC9878410
OpenAlexW4317358987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.